Shouyao Holdings Beijing Co. Ltd. Class ASSE: 688197

Announcement on Voluntary Disclosure of MAT2A Inhibitor SY-9453 Obtaining the Notice of Approval for Drug Clinical Trials

· Issued by Shouyao Holdings Beijing Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of MAT2A Inhibitor SY-9453 Obtaining the Notice of Approval for Drug Clinical Trials

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis